Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations.
This article presents the World Health Organizations (WHO) evidence and recommendations for the use of Haemophilus influenzae type b vaccination from the WHO position paper on H. influenzae type b (Hib) Vaccination - July 2013 recently published in the Weekly Epidemiological Record [1]. This position paper summarizes the WHO position on the inclusion of Hib vaccines in all national immunization programmes, recent developments in the field and the potential of different Hib immunization schedules to further reduce morbidity and mortality. The current document replaces the position paper on the use of Hib vaccines published in 2006 [2]. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2013 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html.